RedHill Biopharma Profile

0.97
USD 0.00  0.00%
100%
0%

RedHill Biopharma Risk Profiles

Key Fundamentals

RedHill Biopharma Against Markets

RedHill Biopharma Ltd., a biopharmaceutical company, primarily focuses on the development and commercialization of late clinicalstage, proprietary, orallyadministered, small molecule drugs for the treatment of inflammatory and gastrointestinal diseases, and cancer. more
NameRedHill Biopharma Ltd
CEOOri ShiloView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressTel Aviv,
ExchangeOTC Market
BenchmarkDOW
Websitewww.redhillbio.com
Contact Number972 3 541 3131
CurrencyUSD - US Dollar

Diversify with RedHill Biopharma Ltd

Build Optimal Portfolios
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add RedHill Biopharma Ltd to your portfolio

Directors

RedHill Biopharma Corporate Directors
Ofer Tsimchi Director
Shmuel Cabilly Director
Kenneth Reed Director, Ph.D
Additionally take a look at Your Equity Center. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.